The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT07134205 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07134205
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-06-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.